Abstract
Zinc has been shown to have a positive effect on recovery from pneumonia, colds, and diarrhea. There is also evidence of a link between low zinc levels and the severity of the novel coronavirus infection, leading to active study of its use as a non-specific prophylaxis and adjuvant therapy for COVID-19. The most pronounced effect of zinc supplementation is expected in individuals with subclinical or severe zinc deficiency. Due to the high incidence of zinc deficiency and its significant contribution to a wide range of pathologies, zinc deficiency correction is an economically feasible intervention. Nutrition correction using the Zinc Chelate dietary supplement increases resistance to acute respiratory viral infections, alleviates their course, and improves the convalescence period; improvement of the immune locus of the vital domain of intrinsic viability has pleiotropic effects on the aesthetic domain of intrinsic viability.

This publication has 14 references indexed in Scilit: